In COVID-19 clinical update #67, Daniel Griffin reviews antibodies to the virus early in the US, serology testing of blood donations, MIS-C in children under 21, myocarditis in competitive athletes, ER visits for suspected suicide attempts, delta variant in Scotland, Novavax vaccine phase 3 results, vaccine coverage in pregnant women, early monoclonal administration reduces hospitalization and mortality, casirivimab and imdevimab recovery trial results, and CDC guidance on postacute sequelae.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Antiviral antibodies early in US outbreak (CID)
• Serologic testing of US blood donations (CID)
• The virus, what went wrong (PBS)
• MIS-C in children (JAMA)
• Myocarditis in competitive athletes (JAMA)
• ER visits for suspected suicide (MMWR)
• Delta variant in Scotland (Lancet)
• Novavax phase 3 results (Novavax)
• Vaccine coverage in pregnant women (MMWR)
• Early mAb reduces hospitalization and mortality (CID)
• Regen-Cov trial results (Regeneron)
• Guidance on postacute sequelae (CDC)
• Letters read on TWiV 770
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]